Austrianova announces the publication of a peer-reviewed article on the use of implanted Cell-in-a-Box encapsulated cells for the sustained production of the anti-aging protein Klotho in patients

by Walter Gunzburg | Oct 31, 2026 | Press Release

Brian Salmons, Austrianova’s CEO added “This publication provides the background and future perspectives for our ongoing collaboration with Avaí Bio through our joint venture company, Klothonova.  This press release can be viewed online...

Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale SanRaffaele for Diabetes Cell Therapy Program

by Walter Gunzburg | Oct 8, 2026 | News, Press Release

This press release can be viewed online at: https://www.globenewswire.com/news-release/2026/10/07   LAS VEGAS, NEVADA, Oct. 07, 2026 (GLOBE NEWSWIRE) — Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”) and its joint venture partner Austrianova, today...

Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference

by Walter Gunzburg | Sep 26, 2026 | News, Press Release

This press release can be viewed online at: https://ir.avaibio.com/press-releases/2026/avai-bio-and-austrianova-present-encapsulated-cell-approach-to-sustained-klotho-delivery-at-2026-klotho-conference Watch Austrianova Founder & CTO, Prof. Walter Gunzburg...

Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes

by Walter Gunzburg | Aug 13, 2026 | Press Release

This press release can be viewed online at: https://www.globenewswire.com/news-release/2026/08/12/3343647https://www.einpresswire.com/article/634030792/ Agreement combines Austrianova’s Cell-in-a-Box® technology with San Raffaele Hospital’s stem cell-derived beta cell...

Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

by Walter Gunzburg | May 21, 2026 | News

LAS VEGAS, May 20, 2026 /PRNewswire/ — Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today...

SG Austria/Austrianova Announces the Appointment of C. Thomas Paschall, to the Board following the Successful closing of 2025 Financing Round Led by Checkmate Capital Group

by Walter Gunzburg | Apr 23, 2026 | News

“SG Austria/Austrianova appoints biotech investor C. Thomas Paschall to its Board following a successful 2025 funding round, strengthening global growth, partnerships, and strategic expansion initiatives.”   SINGAPORE – April 21, 2026 – SG...

Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies

by Walter Gunzburg | Nov 19, 2025 | News, Press Release

LAS VEGAS, NEVADA, November 18, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture...

Avant Technologies and Austrianova Sign Joint Venture, Licensing Agreement to Advance Klotho-Based Therapies

by Walter Gunzburg | Sep 19, 2025 | News, Press Release

LAS VEGAS, Sept. 18, 2025 /PRNewswire/ — Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and Austrianova (SGAustria Pte. Ltd.), a Singapore-based biotechnology leader, today announced the...

Long-Term Survival of Cellulose Sulphate-Encapsulated Cells and Metronomic Ifosfamide Control Tumour Growth in Pancreatic Cancer Models—A Prelude to Treating Solid Tumours Effectively in Pets and Humans

by Walter Gunzburg | Aug 17, 2024 | Scientific Publications

Austrianova Singapore Pte Ltd., 2 International Business Park, The Strategy @ IBP #09-04, Singapore 609930, Singapore; salmons@sgaustria.com Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria* Correspondence:...

Future Revolution, Global Talent War TV CHOSUN Special Documentary

by Walter Gunzburg | Jan 8, 2024 | Press Release

Austrianova was featured on Korean TV Chosun on 27th Dec 2023 called “Future Revolution, Global Talent War TV CHOSUN Special Documentary”, they were interested in our technology, in why we set up in Singapore and in the internationality of our team and our...